Expanding product line Basepaws has been consistently expanding its product offerings, recently launching a Breed + Health Dog DNA Test and announcing plans to introduce a new direct-to-consumer dog DNA test. This diversification of products presents an opportunity to target new customer segments and drive sales growth.

Strong industry partnerships With the recent acquisition by Zoetis, Basepaws now has the support of a major player in animal health. Leveraging this partnership can lead to collaboration opportunities, joint marketing initiatives, and access to Zoetis's extensive customer base, potentially boosting sales for Basepaws.

Innovative technology stack Basepaws utilizes a comprehensive tech stack including Microsoft Dynamics and Magento, indicating a commitment to leveraging technology for business growth. This advanced technology infrastructure can be highlighted to potential customers as a competitive advantage, showcasing Basepaws as a forward-thinking and efficient partner.

Strategic industry positioning Basepaws' focus on genetic and microbiome data for companion animals sets it apart in the biotechnology research industry. This unique positioning can be used as a selling point to emphasize the company's specialized expertise and tailor-made solutions, enhancing its appeal to customers seeking personalized petcare services.

Market expansion opportunities Basepaws' recent launch of genetic and oral microbiome screening tools for veterinary teams highlights a foray into B2B sales. By targeting veterinary clinics and professionals as potential clients, Basepaws can tap into a new market segment, offering specialized services and fostering long-term partnerships for sustained sales growth.